Document ID: chunk:federal_register_of_legislation:F2024C00944:front:0:p16
Version: federal_register_of_legislation:F2024C00944
Segment Type: other
Provision Reference: 
Character Range: 42485–45162

(a) beginning immediately after the complete specification filed in relation to the application for a standard patent becomes open to public inspection; and
 (b) ending 3 months after the date of publication in the Official Journal of the notice of acceptance under paragraph 49(5)(b) of the Act.

2.6  Prescribed period: notification of assertion of invalidity of innovation patent
  For subsection 28(2) of the Act, the prescribed period for an innovation patent is the period from the date that the complete specification for the patent becomes open to public inspection to immediately before the Commissioner decides to certify the patent.

2.7  Documents to accompany notice of assertion of invalidity
  Notice of an assertion under subsection 27(1) or 28(1) of the Act must, if the assertion is based on a document, have with it:
 (a) a copy of the document; and
 (b) if the document is not in English, a copy of a translation of the document into English; and
 (c) evidence of the date and place of publication of the document.

Chapter 3—From application to acceptance

Part 1—Inventions generally

Division 1—Applications

3.1  Prescribed documents: patent applications
 (1) For the purposes of subsection 29(1) of the Act, an abstract is required to be filed with a patent request made in relation to a complete application.
 (2) For the purposes of subsection 29(1) of the Act, if a complete application for a standard patent is made, the following documents are required to be filed before acceptance:
 (c) if a micro‑organism is deposited with a prescribed depositary institution:
 (i) if the deposit is an original deposit within the meaning of Rule 7.3 of the Budapest Treaty or a new deposit within the meaning of Rule 7.4 of that Treaty—a copy of a receipt issued by the institution under Rule 7 of the Treaty; and
 (ii) if samples of the micro‑organism were transferred to that institution under Rule 5.1(a)(i) of the Treaty—a copy of a receipt issued by the institution under Rule 7 of the Treaty; and
 (iii) if a receipt referred to in subparagraph (i) or (ii) is not in English—a translation of the receipt into English; and
 (d) if the application relies on section 6 of the Act—a notice by the applicant stating the entitlement of the nominated person to rely on the deposit for the purposes of the Act; and
 (e) if the application is an application to which subsection 34(2) of the Act applies—a copy of the court order declaring the applicant to be an eligible person in relation to the invention so far as claimed in a claim of the specification; and
 (f) if the application is an application to which subsection 36(4) of the Act applies—a copy of the